Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Improving the use of pharmaceuticals through patient and community level interventions

Identifieur interne : 002457 ( Main/Exploration ); précédent : 002456; suivant : 002458

Improving the use of pharmaceuticals through patient and community level interventions

Auteurs : Nuria Homedes [États-Unis] ; Antonio Ugalde [États-Unis]

Source :

RBID : ISTEX:9421A940A808C660810B6A740438F86F48737A57

English descriptors

Abstract

Abstract: Pharmaceuticals represent an increasing share of private and public health care expenditures. However, while most governments are interested in ensuring availability and access to drugs, the issue of adequate use of drugs remains a low priority in most third world countries. This paper summarizes the results of interventions conducted in developing countries aimed at improving patients’ compliance with the advice of health professionals and/or to decrease the unnecessary use of drugs by the general population. Forty-five studies were identified through literature searches and networking; and only about a third of them fulfilled the eligibility criteria for inclusion in the review. Given the paucity of information available and the importance of the topic the authors report on all 45 studies identified. Although much remains to be explored there are several interventions that deserve to be highlighted. The authors argue that improving the use of pharmaceuticals through interventions directed only to consumers may have a small impact and suggest that in order to obtain meaningful changes it might be necessary to design interventions to modify the behavior of all the actors in the medication cycle (manufacturers, health professionals, retailers, consumers and governments). They suggest that the extraordinary therapeutic effects of antibiotics, coupled with the problems that may arise when they are inappropriately used and with the extraordinary amount of resources spent on antibiotics worldwide justify a global effort to reduce their inappropriate use and promote their adequate administration. The complexity of this type of intervention would require the support of the pharmaceutical industry, governments, private foundations, and international organizations.

Url:
DOI: 10.1016/S0277-9536(00)00131-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Improving the use of pharmaceuticals through patient and community level interventions</title>
<author>
<name sortKey="Homedes, Nuria" sort="Homedes, Nuria" uniqKey="Homedes N" first="Nuria" last="Homedes">Nuria Homedes</name>
</author>
<author>
<name sortKey="Ugalde, Antonio" sort="Ugalde, Antonio" uniqKey="Ugalde A" first="Antonio" last="Ugalde">Antonio Ugalde</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9421A940A808C660810B6A740438F86F48737A57</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0277-9536(00)00131-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-FXF0562Z-G/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C80</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C80</idno>
<idno type="wicri:Area/Istex/Curation">001C80</idno>
<idno type="wicri:Area/Istex/Checkpoint">001274</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001274</idno>
<idno type="wicri:doubleKey">0277-9536:2000:Homedes N:improving:the:use</idno>
<idno type="wicri:Area/Main/Merge">002485</idno>
<idno type="wicri:Area/Main/Curation">002457</idno>
<idno type="wicri:Area/Main/Exploration">002457</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Improving the use of pharmaceuticals through patient and community level interventions</title>
<author>
<name sortKey="Homedes, Nuria" sort="Homedes, Nuria" uniqKey="Homedes N" first="Nuria" last="Homedes">Nuria Homedes</name>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Public Health, University of Texas-Houston at El Paso, El Paso, TX 79902</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ugalde, Antonio" sort="Ugalde, Antonio" uniqKey="Ugalde A" first="Antonio" last="Ugalde">Antonio Ugalde</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Sociology, University of Texas, Austin, TX</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Social Science & Medicine</title>
<title level="j" type="abbrev">SSM</title>
<idno type="ISSN">0277-9536</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">52</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="99">99</biblScope>
<biblScope unit="page" to="134">134</biblScope>
</imprint>
<idno type="ISSN">0277-9536</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0277-9536</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acute diarrhoea</term>
<term>Adequate administration</term>
<term>Advance organizer</term>
<term>Adverse drug reactions</term>
<term>Africa wilkinson</term>
<term>Antenatal clinics</term>
<term>Antibiotic</term>
<term>Antidiarrheal</term>
<term>Antimicrobial resistance</term>
<term>Appropriate comparison group</term>
<term>Appropriate management</term>
<term>Appropriate period</term>
<term>Attendance compliance</term>
<term>Behavior health status</term>
<term>Bernades silva</term>
<term>Better compliers</term>
<term>Blister</term>
<term>Blister packaging</term>
<term>Blister packs</term>
<term>Blood pressure</term>
<term>Blood pressure control</term>
<term>Blood pressure stations</term>
<term>British journal</term>
<term>Bronfman</term>
<term>Caretaker</term>
<term>Chemoprophylaxis</term>
<term>Chemotherapy</term>
<term>Childhood diarrhea</term>
<term>Chloroquine</term>
<term>Chowdhury</term>
<term>Clinic</term>
<term>Clinical pharmacy</term>
<term>Clinical status</term>
<term>Community awareness</term>
<term>Community health workers</term>
<term>Comparison district</term>
<term>Comparison group</term>
<term>Compliance</term>
<term>Compliance improvement</term>
<term>Compliance rate</term>
<term>Compliance rates</term>
<term>Control area</term>
<term>Control case</term>
<term>Control group</term>
<term>Control groups</term>
<term>Control groups group</term>
<term>Control town</term>
<term>Costa rica</term>
<term>Defaulter</term>
<term>Design interventions</term>
<term>Diarrea aguda</term>
<term>Diarrhea</term>
<term>Diarrhea cases</term>
<term>Diarrheal diseases</term>
<term>Diastolic blood pressure</term>
<term>District level</term>
<term>Dorantes jimenez</term>
<term>Drug expenditures</term>
<term>Drug packaging</term>
<term>Drug vendors</term>
<term>Early education</term>
<term>Eligibility criteria</term>
<term>Elsevier science</term>
<term>Essential drugs</term>
<term>Evaluation criteria</term>
<term>Evaluation design</term>
<term>Evaluation design criteria</term>
<term>Evaluation designs</term>
<term>Evaluation sample</term>
<term>Experimental group</term>
<term>Experimental groups</term>
<term>Extra liquids</term>
<term>Failure rate</term>
<term>Family intervention</term>
<term>Family member</term>
<term>Family members</term>
<term>Family support</term>
<term>Full regimen</term>
<term>Gambia</term>
<term>General population</term>
<term>General practitioners</term>
<term>Greater chance</term>
<term>Group sessions</term>
<term>Group teaching</term>
<term>Guiscafre</term>
<term>Gutierrez</term>
<term>Haynes</term>
<term>Health action information network</term>
<term>Health care</term>
<term>Health care providers</term>
<term>Health centers</term>
<term>Health education</term>
<term>Health education message</term>
<term>Health practitioners</term>
<term>Health problem</term>
<term>Health problems</term>
<term>Health professionals</term>
<term>Health status</term>
<term>Health workers</term>
<term>High blood pressure</term>
<term>High esteem</term>
<term>High intensity intervention</term>
<term>High turnover</term>
<term>Homedes</term>
<term>Honduras</term>
<term>Household storage</term>
<term>Hypertensive</term>
<term>Hypertensive patients</term>
<term>Illiterate patients</term>
<term>Inappropriate distribution</term>
<term>Inclusion criteria</term>
<term>Individual teaching</term>
<term>Intensity intervention</term>
<term>International journal</term>
<term>International organizations</term>
<term>International union</term>
<term>Intervention</term>
<term>Intervention area</term>
<term>Intervention group</term>
<term>Intervention groups</term>
<term>Intervention towns</term>
<term>Kane</term>
<term>Kenya</term>
<term>Lancet</term>
<term>Latin america</term>
<term>Less disruption</term>
<term>Life style</term>
<term>Lima</term>
<term>Local stores</term>
<term>Lopez linares</term>
<term>Lung disease</term>
<term>Main reason</term>
<term>Malaria</term>
<term>Malaria chemoprophylaxis</term>
<term>Male patients</term>
<term>Mass media campaign</term>
<term>Meaningful changes</term>
<term>Medical anthropology unit</term>
<term>Medical care</term>
<term>Medical regimens</term>
<term>Medication</term>
<term>Medication compliance</term>
<term>Medication cycle</term>
<term>Medicine</term>
<term>Mercado martinez</term>
<term>Miller pisan</term>
<term>Mills booth</term>
<term>More subjects</term>
<term>Mortality rate</term>
<term>Mortality rates</term>
<term>Munoz</term>
<term>Ndings</term>
<term>Ndings compliance</term>
<term>Nurse talks</term>
<term>Oral rehydration therapy</term>
<term>Organizer</term>
<term>Other cases</term>
<term>Other words</term>
<term>Outcome measures</term>
<term>Outcomes compliance</term>
<term>Outpatient</term>
<term>Overall levels</term>
<term>Packaging</term>
<term>Pamphlet</term>
<term>Paredes</term>
<term>Particular disease</term>
<term>Patient compliance</term>
<term>Patients group</term>
<term>Percentage comple</term>
<term>Personal patient record book</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical industry</term>
<term>Pharmacist</term>
<term>Pharmacy clerks</term>
<term>Poor compliance</term>
<term>Poor packaging</term>
<term>Positive impact</term>
<term>Positive results</term>
<term>Practitioner</term>
<term>Pregnant women</term>
<term>Prescripcion medica</term>
<term>Prescription</term>
<term>Prescription errors</term>
<term>Prescription habits</term>
<term>Prevalent health problems</term>
<term>Primary health care settings</term>
<term>Programme</term>
<term>Provider</term>
<term>Public health</term>
<term>Public health care expenditures</term>
<term>Public markets</term>
<term>Public meetings</term>
<term>Quezon city</term>
<term>Randomized</term>
<term>Rational drug</term>
<term>Regimen</term>
<term>Relapse rate</term>
<term>Reminder letters</term>
<term>Respiratory infections</term>
<term>Rural areas</term>
<term>Rural community</term>
<term>Rural zimbabwean communities</term>
<term>Same community</term>
<term>Same time</term>
<term>Sample size</term>
<term>Sanitaria panamericana</term>
<term>Selfsupervised patients</term>
<term>Several interventions</term>
<term>Severe cases</term>
<term>Short course chemotherapy</term>
<term>Simple episodes</term>
<term>Small mass media</term>
<term>Social science</term>
<term>Social science medicine</term>
<term>Social worker</term>
<term>Special attention</term>
<term>Standard treatment</term>
<term>Study district</term>
<term>Study group</term>
<term>Subdistricts phase</term>
<term>Successful interventions</term>
<term>Supervision methods</term>
<term>Systematic review</term>
<term>Third world countries</term>
<term>Traditional healers</term>
<term>Treatment compliance</term>
<term>Treatment program</term>
<term>Treatment regimen</term>
<term>Treatment success</term>
<term>Tropical medicine</term>
<term>Tuberculosis</term>
<term>Tuberculosis control</term>
<term>Tuberculosis hospital</term>
<term>Ugalde</term>
<term>Unsafe injections</term>
<term>Village doctors</term>
<term>Visual aids</term>
<term>Watery diarrhea</term>
<term>Wilkinson</term>
<term>World bank</term>
<term>World health organization</term>
<term>World market</term>
<term>Year table</term>
<term>Young children</term>
<term>Zhang</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Pharmaceuticals represent an increasing share of private and public health care expenditures. However, while most governments are interested in ensuring availability and access to drugs, the issue of adequate use of drugs remains a low priority in most third world countries. This paper summarizes the results of interventions conducted in developing countries aimed at improving patients’ compliance with the advice of health professionals and/or to decrease the unnecessary use of drugs by the general population. Forty-five studies were identified through literature searches and networking; and only about a third of them fulfilled the eligibility criteria for inclusion in the review. Given the paucity of information available and the importance of the topic the authors report on all 45 studies identified. Although much remains to be explored there are several interventions that deserve to be highlighted. The authors argue that improving the use of pharmaceuticals through interventions directed only to consumers may have a small impact and suggest that in order to obtain meaningful changes it might be necessary to design interventions to modify the behavior of all the actors in the medication cycle (manufacturers, health professionals, retailers, consumers and governments). They suggest that the extraordinary therapeutic effects of antibiotics, coupled with the problems that may arise when they are inappropriately used and with the extraordinary amount of resources spent on antibiotics worldwide justify a global effort to reduce their inappropriate use and promote their adequate administration. The complexity of this type of intervention would require the support of the pharmaceutical industry, governments, private foundations, and international organizations.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Homedes, Nuria" sort="Homedes, Nuria" uniqKey="Homedes N" first="Nuria" last="Homedes">Nuria Homedes</name>
</noRegion>
<name sortKey="Homedes, Nuria" sort="Homedes, Nuria" uniqKey="Homedes N" first="Nuria" last="Homedes">Nuria Homedes</name>
<name sortKey="Ugalde, Antonio" sort="Ugalde, Antonio" uniqKey="Ugalde A" first="Antonio" last="Ugalde">Antonio Ugalde</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002457 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002457 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:9421A940A808C660810B6A740438F86F48737A57
   |texte=   Improving the use of pharmaceuticals through patient and community level interventions
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021